AR045914A1 - Compuesto alcoholico terciario del 8-azoniabiciclo [3.2.1] octano, composicion farmaceutica que lo comprende y su uso para preparar esta ultima - Google Patents
Compuesto alcoholico terciario del 8-azoniabiciclo [3.2.1] octano, composicion farmaceutica que lo comprende y su uso para preparar esta ultimaInfo
- Publication number
- AR045914A1 AR045914A1 ARP040102499A ARP040102499A AR045914A1 AR 045914 A1 AR045914 A1 AR 045914A1 AR P040102499 A ARP040102499 A AR P040102499A AR P040102499 A ARP040102499 A AR P040102499A AR 045914 A1 AR045914 A1 AR 045914A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- pharmaceutical composition
- formula
- prepare
- acetylcholine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Un compuesto alcohólico terciario del 8-azoniabiciclo[3.2.1]octano representado por la fórmula (1), en la que: R2 y R3 se seleccionan, independientemente, del grupo constituido por grupos alquilo inferiores de cadena lineal o ramificada (que tienen preferiblemente C1-6), grupos cicloalquilos (C1-6), cicloalquil-alquilo(C6-10), 2-tienilo, 2-piridilo, fenilo, fenilo sustituido con un grupo alquilo que no tiene más de 4 átomos de carbono y fenilo sustituido con un grupo alcoxi que no tiene más de 4 átomos de carbono; y X- representa un anión asociado con la carga positiva del átomo de N; de tal modo que el compuesto es una sal cuaternaria. Composición farmacéutica para el tratamiento de enfermedades mediadas por los receptores muscarínicos de la acetilcolina, que comprende el compuesto de la fórmula (1) y un vehículo del mismo farmacéuticamente aceptable. Uso del compuesto de la fórmula (1) para preparar una composición farmacéutica útil para inhibir la unión de la acetilcolina a sus receptores en un mamífero que lo necesite, mediante la administración de una cantidad segura y eficaz de dicho compuesto. De esta forma se puede tratar una enfermedad mediada por un receptor muscarínico de la acetilcolina, en el que la acetilcolina se une a dicho receptor, tales como las enfermedades del tracto respiratorio.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48798203P | 2003-07-17 | 2003-07-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR045914A1 true AR045914A1 (es) | 2005-11-16 |
Family
ID=34102736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040102499A AR045914A1 (es) | 2003-07-17 | 2004-07-15 | Compuesto alcoholico terciario del 8-azoniabiciclo [3.2.1] octano, composicion farmaceutica que lo comprende y su uso para preparar esta ultima |
Country Status (19)
Country | Link |
---|---|
US (1) | US7495010B2 (es) |
EP (1) | EP1648461A4 (es) |
JP (1) | JP2007525478A (es) |
KR (1) | KR20060054316A (es) |
CN (1) | CN1822839A (es) |
AR (1) | AR045914A1 (es) |
AU (1) | AU2004259238A1 (es) |
BR (1) | BRPI0412537A (es) |
CA (1) | CA2532433A1 (es) |
IL (1) | IL172912A0 (es) |
IS (1) | IS8296A (es) |
MA (1) | MA27901A1 (es) |
MX (1) | MXPA06000663A (es) |
NO (1) | NO20060777L (es) |
PE (1) | PE20050250A1 (es) |
RU (1) | RU2006104851A (es) |
TW (1) | TW200519108A (es) |
WO (1) | WO2005009362A2 (es) |
ZA (1) | ZA200600167B (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ556424A (en) * | 2003-10-14 | 2008-12-24 | Glaxo Group Ltd | Muscarinic Acetylcholine receptor antagonists |
EA200600787A1 (ru) * | 2003-10-17 | 2006-08-25 | Глэксо Груп Лимитед | Антагонисты мускариновых ацетилхолиновых рецепторов |
PE20050489A1 (es) * | 2003-11-04 | 2005-09-02 | Glaxo Group Ltd | Antagonistas de receptores de acetilcolina muscarinicos |
WO2005087236A1 (en) * | 2004-03-11 | 2005-09-22 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
JP2007529513A (ja) * | 2004-03-17 | 2007-10-25 | グラクソ グループ リミテッド | M3ムスカリン性アセチルコリン受容体アンタゴニスト |
WO2005094251A2 (en) * | 2004-03-17 | 2005-10-13 | Glaxo Group Limited | M3muscarinic acetylcholine receptor antagonists |
AU2012202307B2 (en) * | 2004-04-27 | 2015-05-07 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
UY28871A1 (es) * | 2004-04-27 | 2005-11-30 | Glaxo Group Ltd | Antagonistas del receptor de acetilcolina muscarinico |
EP1747219A4 (en) * | 2004-05-13 | 2010-05-26 | Glaxo Group Ltd | Antagonists of muscarinic acetylcholine receptor |
JP2008520579A (ja) * | 2004-11-15 | 2008-06-19 | グラクソ グループ リミテッド | 新規m3ムスカリン性アセチルコリン受容体アンタゴニスト |
EP1937267A4 (en) * | 2005-08-02 | 2009-08-26 | Glaxo Group Ltd | M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS |
EP1937068A4 (en) * | 2005-08-18 | 2010-08-04 | Glaxo Group Ltd | ANTAGONISTS OF ACETYLCHOLINE MUSCARINIC RECEPTORS |
CL2009000250A1 (es) | 2008-02-06 | 2009-09-11 | Glaxo Group Ltd | Compuestos derivados de pirazolo[3,4-b]piridina carboxamida; composicion farmaceutica que los comprende; y su uso en el tratamiento del asma, epoc y rinitis. |
PE20091563A1 (es) | 2008-02-06 | 2009-11-05 | Glaxo Group Ltd | Farmacoforos duales - antagonistas muscarinicos de pde4 |
AR070564A1 (es) | 2008-02-06 | 2010-04-21 | Glaxo Group Ltd | Derivados de 1h-pirazolo[3,4-b]piridin-5-ilo,inhibidores de fosfodiesterasas pde4 y antagonistas de receptores muscarinicos de acetilcolina(machr), utiles en el tratamiento y/o profilaxis de enfermedades respiratorias y alergicas,y composiciones farmaceuticas que los comprenden |
WO2010094643A1 (en) | 2009-02-17 | 2010-08-26 | Glaxo Group Limited | Quinoline derivatives and their uses for rhinitis and urticaria |
EP3248970A1 (en) | 2016-05-27 | 2017-11-29 | Zentiva K.S. | Forms of umeclidinium bromide |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2800481A (en) * | 1955-07-01 | 1957-07-23 | Smith Kline French Lab | Tertiary alcohol derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof |
US2800478A (en) * | 1955-07-01 | 1957-07-23 | Smith Kline French Lab | 3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof |
US2800482A (en) * | 1955-07-01 | 1957-07-23 | Smith Kline French Lab | Olefinic derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof |
AT298118B (de) * | 1967-06-08 | 1972-04-25 | Siemens Ag | Verfahren zur Umsetzung von Spannungen in digitale Werte und Vorrichtung zur Durchführung des Verfahrens |
CY1308A (en) | 1979-12-06 | 1985-12-06 | Glaxo Group Ltd | Device for dispensing medicaments |
DE3274065D1 (de) | 1981-07-08 | 1986-12-11 | Draco Ab | Powder inhalator |
GB2169265B (en) | 1982-10-08 | 1987-08-12 | Glaxo Group Ltd | Pack for medicament |
CA1224992A (en) | 1982-10-08 | 1987-08-04 | Robert E. Newell | Device for administering medicament to patients |
FI88112C (fi) | 1985-07-30 | 1993-04-13 | Glaxo Group Ltd | Anordning foer administrering av laekemedel till patienter |
IT1204826B (it) | 1986-03-04 | 1989-03-10 | Chiesi Farma Spa | Composizioni farmaceutiche per inalazione |
GB9004781D0 (en) * | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
US5780466A (en) * | 1995-01-30 | 1998-07-14 | Sanofi | Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present |
EP0944626A4 (en) * | 1996-12-02 | 2002-09-04 | Univ Georgetown | TROPANE DERIVATIVES AND SYNTHESIS METHOD |
US6248752B1 (en) * | 1998-02-27 | 2001-06-19 | Charles Duane Smith | Azabicyclooctane compositions and methods for enhancing chemotherapy |
US6262066B1 (en) * | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
ES2165768B1 (es) * | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
WO2002004402A1 (fr) * | 2000-07-11 | 2002-01-17 | Banyu Pharmaceutical Co., Ltd. | Derives d'ester |
CZ2004501A3 (cs) * | 2001-10-17 | 2004-09-15 | Ucb, S.A. | Chinuklidinové deriváty, způsoby jejich přípravy a jejich použití jako M2 a/nebo M3 inhibitoru muskarinového receptoru |
TW200410951A (en) * | 2002-08-06 | 2004-07-01 | Glaxo Group Ltd | M3 muscarinic acetylcholine receptor antagonists |
JP2006522161A (ja) * | 2003-04-07 | 2006-09-28 | グラクソ グループ リミテッド | M3ムスカリン性アセチルコリン受容体拮抗剤 |
PE20050327A1 (es) * | 2003-07-17 | 2005-06-08 | Glaxo Group Ltd | Derivados de 8-azoniabiciclo[3.2.1]octano como antagonistas de los receptores muscarinicos de la acetilcolina |
AR048573A1 (es) * | 2003-07-17 | 2006-05-10 | Glaxo Group Ltd | Compuesto de 8-azoniabiciclo[3.2.1]octano sustituido en la posicion 3, composicion farmceutica que lo comprende y su uso para preparar esta ultima |
NZ556424A (en) * | 2003-10-14 | 2008-12-24 | Glaxo Group Ltd | Muscarinic Acetylcholine receptor antagonists |
EA200600787A1 (ru) * | 2003-10-17 | 2006-08-25 | Глэксо Груп Лимитед | Антагонисты мускариновых ацетилхолиновых рецепторов |
PE20050489A1 (es) * | 2003-11-04 | 2005-09-02 | Glaxo Group Ltd | Antagonistas de receptores de acetilcolina muscarinicos |
CN100569760C (zh) * | 2003-11-21 | 2009-12-16 | 施万制药 | 具有β2肾上腺素能受体激动剂和毒蕈碱性受体拮抗剂活性的化合物 |
PE20050897A1 (es) * | 2003-12-03 | 2005-11-06 | Glaxo Group Ltd | Nuevos antagonistas del receptor muscarinico m3 de acetilcolina |
PE20050861A1 (es) * | 2003-12-03 | 2005-12-10 | Glaxo Group Ltd | Derivados de sales ciclicas de amonio cuaternario como antagonistas del receptor muscarinico de acetilcolina |
US20070185090A1 (en) * | 2004-03-17 | 2007-08-09 | Jakob Busch-Petersen | Muscarinic acetylchoine receptor antagonists |
JP2007529513A (ja) * | 2004-03-17 | 2007-10-25 | グラクソ グループ リミテッド | M3ムスカリン性アセチルコリン受容体アンタゴニスト |
WO2005094251A2 (en) * | 2004-03-17 | 2005-10-13 | Glaxo Group Limited | M3muscarinic acetylcholine receptor antagonists |
US20070185088A1 (en) * | 2004-03-17 | 2007-08-09 | Jakob Busch-Petersen | M3 muscarinic acetylchoine receptor antagonists |
UY28871A1 (es) * | 2004-04-27 | 2005-11-30 | Glaxo Group Ltd | Antagonistas del receptor de acetilcolina muscarinico |
EP1747219A4 (en) * | 2004-05-13 | 2010-05-26 | Glaxo Group Ltd | Antagonists of muscarinic acetylcholine receptor |
PE20060367A1 (es) * | 2004-05-28 | 2006-04-28 | Glaxo Group Ltd | Compuestos 8-azoniabiciclo[3.2.1]octanos como antagonistas del receptor de acetilcolina muscarinico |
US20090258858A1 (en) | 2004-10-29 | 2009-10-15 | Jakob Busch-Petersen | Muscarinic acetylcholine receptor antagonists |
WO2006055503A2 (en) | 2004-11-15 | 2006-05-26 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
JP2008520579A (ja) | 2004-11-15 | 2008-06-19 | グラクソ グループ リミテッド | 新規m3ムスカリン性アセチルコリン受容体アンタゴニスト |
PE20061162A1 (es) | 2004-12-06 | 2006-10-14 | Smithkline Beecham Corp | Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos |
PE20060826A1 (es) | 2004-12-06 | 2006-10-08 | Smithkline Beecham Corp | Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende |
WO2006065755A2 (en) | 2004-12-13 | 2006-06-22 | Glaxo Group Limited | Quaternary ammonium salts of fused hetearomatic amines as novel muscarinic acetylcholine receptor antagonists |
WO2006065788A2 (en) | 2004-12-13 | 2006-06-22 | Glaxo Group Limited | Novel muscarinic acetylcholine receptor antagonists |
WO2007018508A1 (en) | 2005-07-28 | 2007-02-15 | Glaxo Group Limited | Novel m3 muscarinic acetycholine receptor antagonists |
WO2007018514A1 (en) | 2005-07-28 | 2007-02-15 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
EP1937267A4 (en) | 2005-08-02 | 2009-08-26 | Glaxo Group Ltd | M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS |
WO2007016650A2 (en) | 2005-08-02 | 2007-02-08 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
EP1937068A4 (en) | 2005-08-18 | 2010-08-04 | Glaxo Group Ltd | ANTAGONISTS OF ACETYLCHOLINE MUSCARINIC RECEPTORS |
-
2004
- 2004-07-15 AR ARP040102499A patent/AR045914A1/es unknown
- 2004-07-15 TW TW093121063A patent/TW200519108A/zh unknown
- 2004-07-15 PE PE2004000674A patent/PE20050250A1/es not_active Application Discontinuation
- 2004-07-16 JP JP2006520387A patent/JP2007525478A/ja active Pending
- 2004-07-16 WO PCT/US2004/023041 patent/WO2005009362A2/en active Application Filing
- 2004-07-16 CA CA002532433A patent/CA2532433A1/en not_active Abandoned
- 2004-07-16 KR KR1020067001001A patent/KR20060054316A/ko not_active Application Discontinuation
- 2004-07-16 AU AU2004259238A patent/AU2004259238A1/en not_active Abandoned
- 2004-07-16 MX MXPA06000663A patent/MXPA06000663A/es unknown
- 2004-07-16 BR BRPI0412537-1A patent/BRPI0412537A/pt not_active IP Right Cessation
- 2004-07-16 RU RU2006104851/04A patent/RU2006104851A/ru not_active Application Discontinuation
- 2004-07-16 EP EP04778509A patent/EP1648461A4/en not_active Withdrawn
- 2004-07-16 US US10/565,048 patent/US7495010B2/en not_active Expired - Fee Related
- 2004-07-16 CN CNA2004800206526A patent/CN1822839A/zh active Pending
-
2005
- 2005-12-29 IL IL172912A patent/IL172912A0/en unknown
-
2006
- 2006-01-06 MA MA28705A patent/MA27901A1/fr unknown
- 2006-01-06 ZA ZA200600167A patent/ZA200600167B/en unknown
- 2006-02-13 IS IS8296A patent/IS8296A/is unknown
- 2006-02-17 NO NO20060777A patent/NO20060777L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1648461A4 (en) | 2009-04-01 |
WO2005009362A3 (en) | 2005-04-07 |
NO20060777L (no) | 2006-04-11 |
CA2532433A1 (en) | 2005-02-03 |
MXPA06000663A (es) | 2006-03-30 |
CN1822839A (zh) | 2006-08-23 |
ZA200600167B (en) | 2007-01-31 |
KR20060054316A (ko) | 2006-05-22 |
MA27901A1 (fr) | 2006-05-02 |
US7495010B2 (en) | 2009-02-24 |
BRPI0412537A (pt) | 2006-09-19 |
AU2004259238A1 (en) | 2005-02-03 |
IL172912A0 (en) | 2006-06-11 |
RU2006104851A (ru) | 2006-06-27 |
IS8296A (is) | 2006-02-13 |
US20060178396A1 (en) | 2006-08-10 |
JP2007525478A (ja) | 2007-09-06 |
TW200519108A (en) | 2005-06-16 |
EP1648461A2 (en) | 2006-04-26 |
WO2005009362A2 (en) | 2005-02-03 |
PE20050250A1 (es) | 2005-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR045914A1 (es) | Compuesto alcoholico terciario del 8-azoniabiciclo [3.2.1] octano, composicion farmaceutica que lo comprende y su uso para preparar esta ultima | |
AR048573A1 (es) | Compuesto de 8-azoniabiciclo[3.2.1]octano sustituido en la posicion 3, composicion farmceutica que lo comprende y su uso para preparar esta ultima | |
EA200870423A1 (ru) | Производные триазолпиразинов, применимые в качестве противораковых агентов | |
BR0111377A (pt) | Derivados de tiofeno úteis como agentes anticancerìgenos | |
ECSP056134A (es) | Derivados de quinuclidina que se enlazan con los receptores muscarínicos m3 | |
UY28132A1 (es) | Derivados de pirrolopirimidina | |
BRPI0508461B8 (pt) | diaminopirimidinas, seus usos, e composição farmacêutica | |
ES2606043T3 (es) | Derivados de biarilo como moduladores de nAChR | |
BRPI0416656A (pt) | compostos de pirrolopirimidina úteis no tratamento do cáncer | |
WO2007138472A3 (en) | Triazolopyridazine derivatives | |
FR2903107B1 (fr) | Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique | |
AR088919A2 (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y uso | |
ATE360630T1 (de) | Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors | |
AR054411A1 (es) | Combinacion farmaceutica que comprende un compuesto olefinico de 8- azoniabiciclo [ 3.2.1] octano y uno o mas ingredientes terapeuticos distintos, composicion farmaceutica que la comprende y uso de dichos componentes para prepararla | |
EA200600892A1 (ru) | Новые хинолиновые производные | |
EA200870448A1 (ru) | Тризамещенные 1,2,4-триазолы | |
AR045913A1 (es) | Derivados olefinicos de 8-azabiciclo[3,2,1]octanos como antagonistas de receptores muscarinicos de acetilcolina | |
TW200639159A (en) | Treatment of pain | |
AR067770A1 (es) | Derivados de tiazol y ditiazol para el tratamiento de diabetes | |
IN2014DN05869A (es) | ||
JP2012505879A5 (es) | ||
AR046114A1 (es) | Compuesto de 8- azoniabiciclo (3.2.1) octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos y uso del compuesto para preparar dicha composicion | |
KR910015580A (ko) | 신규 콜린에스테라제 억제제로서의 삼환-일환식 아민 | |
AR047730A1 (es) | Uso de los derivados de 3-aminocaprolactam como agentes anti-inflamatorios | |
AR029259A1 (es) | Compuestos 1,1'(1,2 etendiilo) bis (benceno) sustituidos, un proceso para su preparacion composiciones farmaceuticas y el uso de dichos compuestos para preparar agentes intensificadores de la absorcion de glucosa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |